Fingerprint
Dive into the research topics of 'Phase II trial of 4′-deoxydoxorubicin (esorubicin) in hormone resistant prostate cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of 4′-deoxydoxorubicin (esorubicin) in hormone resistant prostate cancer
Ted Braich, Frederick R. Ahmann, Harinder S. Garewal, Aurelia Robertone, Sydney E. Salmon
Research output: Contribution to journal › Article › peer-review
10
Scopus
citations